Blog

In a groundbreaking study, researchers from Stony Brook Medicine and Yale School of Medicine have identified a protein known as K17 as a significant contributor to the resistance of pancreatic cancer...

Recent research led by a team from Stony Brook Medicine and Yale School of Medicine has unveiled a promising target in the ongoing battle against pancreatic cancer: a protein known as K17. This...

Recent advancements in cancer research have unveiled a new potential approach for treating aggressive brain tumors, particularly high-grade gliomas, which have historically posed significant...

Explore how MAMMAL connects gene expression, SMILES strings, proteins, and drug response prediction for cancer drug discovery and precision oncology research.

MAMMAL AI is a multimodal biomedical foundation model for drug discovery. Learn what Molecular Aligned Multi-Modal Architecture and Language means and why it matters.

Learn how to use MAMMAL, IBM Research's multimodal biomedical foundation model, for protein, small-molecule, gene-expression, and drug discovery research workflows.

Recent research from Wits University has sparked excitement in the cancer research community, revealing that the bacteria present in our saliva could serve as a crucial early warning sign for...

In a significant move towards advancing cancer research and improving patient care, the Association of American Cancer Institutes (AACI) is urging federal lawmakers to support the Knock Out Cancer...

In a significant move for cancer research, the Association of American Cancer Institutes (AACI) has expressed strong support for the Knock Out Cancer Act, a proposed legislation aimed at increasing...

Recent findings from a comprehensive study conducted by researchers at Houston Methodist have brought to light significant changes in breast cancer risk and outcomes for women across the United...

In an exciting breakthrough, scientists are harnessing the power of click chemistry to create a new frontier in cancer treatment known as theranostics. This innovative approach merges diagnosis and...

In a significant advancement for cancer treatments, Galvanize Therapeutics has received FDA clearance for its Aliya EX Generator, a device that utilizes pulsed electric fields (PEF) to enhance...

Recent findings from a pilot study conducted by researchers at Children's Hospital Los Angeles have unveiled promising news for the treatment of high-risk neuroblastoma in children. This rare but...

Recent findings from researchers at Children’s Hospital Los Angeles have shed light on a promising approach to treating high-risk neuroblastoma, a serious type of cancer that primarily affects...

In a significant advancement for cancer research, a team led by Dr. Jason Pitt at the Cancer Science Institute of Singapore has unveiled an open-access tool that decodes unique DNA change patterns in...

Chemotherapy is a cornerstone of cancer treatment, bringing hope to countless patients. Yet, as many know all too well, not all tumors respond effectively to these drugs, and some initially...

Recent research from Houston Methodist has unveiled important insights into the complexities of chemotherapy resistance, a challenge that many cancer patients face during their treatment journey. The...

In a significant advancement for cancer research, a team of scientists from the National University of Singapore (NUS) has unveiled an open-access tool designed to decode the patterns of DNA changes...

The recent collaboration between Nabsys and Hitachi High-Tech America represents an exciting advancement in the realm of cancer research, specifically in the diagnosis and treatment of hematologic...

Recent advancements in cancer treatment have taken a significant leap forward with the discovery of molecular grappling hooks, which enhance the targeting and effectiveness of cancer drugs. As...